Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Methodiq is a medical telehealth platform launched by Oddity Tech Ltd. that specializes in AI-driven dermatological care. The platform utilizes advanced computer vision and AI-powered skin analysis to provide personalized treatment plans for chronic skin conditions such as acne, hyperpigmentation, and eczema. Methodiq offers a portfolio of 28 core products, including prescription medications, over-the-counter treatments, and supplements, some of which feature proprietary ingredients discovered by the company's biotech unit, Oddity Labs. By integrating digital diagnosis with clinician oversight and progress tracking, the company aims to provide a more effective and accessible alternative to traditional dermatology visits.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Methodiq.